Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 332 clinical trials
Tissue Retractors for Radiation Therapy of Head and Neck Tumors

In addition, quality of life, long-term toxicity as well as local control and overall survival 12 months after radiotherapy are evaluated.

dental caries
head and neck cancer
neck tumor
tumour resection
head and neck neoplasms
  • 0 views
  • 16 Feb, 2024
  • 1 location
Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT Imaging

It is known that HPV+ and HPV- tumors have a different reaction to (chemo)radiotherapy. The exact mechanisms underlying these differences is not yet known but might be caused by changes in vascularity. Therefore the vasculature is imaged with the help of a study specific Gallium-68-DOTA-(RGD)2 PET/CT scan and a CT …

ct perfusion
ct scan
carcinoma
human papillomavirus
oropharyngeal
  • 0 views
  • 16 Feb, 2024
  • 1 location
Nivolumab Ipilimumab and Chemoradiation in Treating Patients With Locally Advanced Pancreatic Cancer.

In these patients, chemotherapy has been the standard treatment for decades, optionally combined with radiotherapy. The results of small randomized trials comparing chemoradiotherapy with chemotherapy of patients with LAPC are divergent. Considering the emerging role of the tumor microenvironment (TME), the combination of checkpoint blocking antibodies with agents that target …

serum bilirubin level
platelet count
carcinoma
immunosuppressive agents
celiac disease
  • 0 views
  • 16 Feb, 2024
  • 1 location
Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide

Compared with non-small-cell lung cancer (NSCLC) SCLC has a unique natural history with a shorter doubling time, higher growth fraction, earlier development of widespread metastases, and uniform initial response to chemo- or radiotherapy. The combination of cis- or carboplatin and etoposide is the standard of care in the first-line treatment …

cns metastases
aptt
autoimmune disease
carboplatin
immunodeficiency
  • 0 views
  • 16 Feb, 2024
  • 1 location
Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion

The study is a randomized, open, prospective phase II study. The aim of the study is to evaluate the safety and feasibility of a hypofractionated, accelerated radiation approach based on the incidence of grade 3-5 NCI Common Terminology Criteria for Adverse Events (NCI-CTC-AE ) toxicity and / or termination of …

  • 0 views
  • 16 Feb, 2024
  • 1 location
Neoadjuvant RCT Versus CT for Patients With Locally Advanced Potentially Resectable Adenocarcinoma of the GEJ

This is a multicenter, prospective, randomized, stratified, controlled, open-label study comparing neoadjuvant radiochemotherapy with FLOT versus FLOT chemotherapy alone fr patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction (GEJ)

flot regimen
kidney function test
aptt
fluorouracil
renal function
  • 0 views
  • 05 Aug, 2020
A Trial of Neoadjuvant mXELOXIRI Versus CRT in the EMVI Positive LARC

Extramural Vascular Invasion Positive(EMVI+) is a high risk of distant metastasis for locally advanced rectal cancer(LARC) after resection. The study is to evaluate the efficacy and safety of XELOXIRI as neoadjuvant chemotherapy alone for EMVI+ LARC in contrast to the efficacy of standard Chemoradiotherapy (CRT).

metastasis
adenocarcinoma of rectum
adenocarcinoma
platelet count
cancer
  • 0 views
  • 05 Aug, 2020
Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer

This study is a one-arm, open, phase II clinical study, and the study subjects are locally advanced and inflammatoryPatients with sexual or early HER2-positive breast cancer entered the trial period after signing informed consentTo evaluate trastuzumab combined with pyrrolitinib and chemotherapy regimen (TCbH+Py) for HER2 positive breastPathologic complete response rate …

HER2
invasive breast cancer
platelet count
her2+ breast cancer
cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors

Screening stage Evaluation of disease Grouping of patients Infusion of cells Surveillance of adverse effect

solid tumor
cancer treatment
hair thinning
decitabine
solid tumour
  • 0 views
  • 16 Feb, 2024
  • 1 location
Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Endometrial Cancer

The retrospective data of our center showed that the sequential radiochemotherapy of "chemotherapy-radiotherapy-chemotherapy" in the "sanwich" mode could improve the survival outcome in patients with advanced endometrial cancer. A multicenter, prospective, randomized controlled study to compare the "sanwich" mode of radiochemotherapy and the "concurrent chemoradiotherapy followed by chemotherapy" mode will …

hysterectomy
endometrial adenocarcinoma
neutrophil count
adenocarcinoma
platelet count
  • 0 views
  • 05 Aug, 2020